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1. Introduction 
Hematopoiesis is regulated by intrinsic gene-regulatory networks, ensuring the rapid 
production of differentiated blood cells for the immediate needs of embryos and generation 
of definitive hematopoietic stem cells (HSCs) that are required for life-long hematopoiesis. 
Homeostasis in bone marrow is dependent on the ability of HSCs to faithfully self-renew 
and to generate progenitor cells that undergo limited proliferation and give rise to 
terminally differentiated cells in the peripheral blood. HSCs are specialized to give rise to all 
elements of the blood system throughout life (Orkin & Zon, 2002, 2008a, 2008b) and are 
capable of self-renewal and differentiation into various lineages of the hematopoietic system 
to form all types of blood cells. Self-renewal is a tightly controlled process through which 
stem cells divide and generate daughter stem cells with properties identical to those of the 
mother cells. However, under certain conditions, HSCs differentiate into progenitor cells 
with less ability to self-renew. Since the discovery of stem cells, intense research aimed at 
understanding the genetic and molecular bases of self-renewal has identified candidate 
regulatory factors involved in the process of HSC self-renewal. These include cell-intrinsic 
regulators, such as transcription factors, signal transducers, cell-cycle inhibitors and surface 
receptors and cell-extrinsic regulators, such as the bone marrow niche and cytokines (He et 
al., 2009). 
Interferon (IFN) is produced by cells of the immune system in response to challenges by 
agents, such as viruses, bacteria and tumor cells. IFNs suppress viral replication, have 
immunomodulatory activities and are used clinically to treat viral diseases and 
malignancies, such as chronic myeloid leukemia (CML)(Stark, 1998). Type I IFNs are 
induced by the genomes of many RNA viruses, and this induction can be mimicked by the 
double-stranded RNA mimetic polyinosinic-polycytidylic acid (poly [I:C]) (Darnell et al. 
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1994, Pichlmair et al. 2007). However, under steady-state conditions in the absence of 
infection, small amount of IFN are produced constitutively (Taniguchi & Takaoka, 2001). 
Recently, Essers et al demonstrated that chronic activation of IFN- pathway impairs 
function of HSCs and acute IFN- treatment promotes the proliferation of dormant HSCs in 
vivo,  and the possibility for new application of type I IFN to target cancer stem cells is 
expected (Essers et al. 2009) .  
Interferon regulatory factors (IRFs) constitute a family of transcription factors involved in 
regulating the development and functions of the immune system (Honda et al., 2006; 
Taniguchi et al., 2001). Interferon regulatory factor-2 (IRF-2) is a transcriptional repressor in 
the interferon system and is thought to function by competing with IRF-1. While IRF-2 acts 
as a repressor for interferon production, IRF-2 exists ubiquitously and is a positive regulator 
for H4, vascular adhesion molecule-1 (VCAM-1), CIITA, gp91 phox, Fas ligand, TPO 
receptor (Vaughan et al.1995, Jesse et al. 1998 , Xi et al. 1999, Luo & Skalnik 1996, Chow et al. 
2000, Stellacci et al. 2004, Masumi et al, 2001). Previously, we demonstrated that IRF-2 
expression into mouse bone marrow hematopoietic stem/progenitor cells induced 
megakaryopoiesis through CD41 promoter activation in an inflammatory states (Masumi et 
al. 2009). IRF-2 regulates cell growth and differentiation through the target gene promoters. 
There are several studies of hematopoietic approaches using IRF-2-/- mice. The 
physiological role in lymphoid and hematopoietic development has been investigated in 
IRF-2-/-mice, in which a general bone marrow suppression of hematopoiesis and B 
lymphopoiesis has been reported (Matsuyama et al. 1993). Recently, a marked reduction of 
hematopoietic stem cells in IRF-2-/- mice involving a type I interferon-dependent 
mechanism was reported (Sato et al. 2009). The population of bone marrow Lin-c-Kit+Sca-1+ 
(KSL) cells is increased in IRF-2-/- mice because of the general enhancement of Sca-1-
positive cells.  
Herein, we show that an enhanced population of Sca-1-positive cells and reduced HSC 
activity in the Lin-Sca-1+c-kit+ fraction were detected in IRF-2-/-mouse bone marrow cells. 
HSC abnormalities in IRF-2-/- mice have been demonstrated to be due to elevated type I 
IFN signaling (Sato et al. 2009). IFN signaling enhances the Sca-1 expression and cell cycle 
progression of HSCs. It was shown that chronic IFN signaling enhances cell cycle 
progression of HSCs in IRF-2-/-mice, resulting in the loss of quiescent HSCs. However, our 
results reveal unknown HSC markers in bone marrow from IRF-2-/- mice. Our present 
findings demonstrate that IRF-2 acts on long-term (LT)-HSCs, not only through protective 
type I IFN responses, but also by directly regulating HSC cell-surface molecules. 
2. Hematopoietic stem cells in bone marrow derived from interferon 
regulatory factor-2-deficient mice 
To analyze the expression of IRFs in mouse bone marrow cells, Gr1/Mac1-positive, B220-
positive, Ter119-positive/lineage (Lin)-negative and KSL (c-kit+Sca-1+Lin-) cells were 
isolated from mouse bone marrow cells by flow cytometry. Real-time polymerase chain 
reaction (PCR) analysis and in situ hybridization showed that IRF-2 was present in 
especially high levels in the CD34-KSL fraction compared with fractions from other lineages 
(Masumi et al., 2009). The CD34-KSL cells from mouse bone marrow were stained with anti-
IRF-2 antibody and DAPI (Fig. 1).  
www.intechopen.com
 Interferon Regulatory Factor-2 Regulates Hematopoietic Stem Cells in Mouse Bone Marrow 
 
93 
 
Fig. 1. CD34-KSL cells were stained with anti-IRF-2 as the primary antibody and then with 
anti-rabbit Alexa594 as the secondary antibody. Concurrently, cells were stained with DAPI.  
2.1 Isolation and characterization of KSL cells 
We showed that IRF-2 was highly localized in the mouse HSCs (CD34-Lin-c-kit+Sca-1+) in 
Fig. 1. To examine the role of IRF-2 in mouse hematopoietic stem cells, we isolated Lin-c-
kit+sca-1+ (KSL) cells from the bone marrow of IRF-2-/-mice (Fig. 2A). The IRF-2-/- mice 
had a larger population of KSL cells than did wild-type mice because of enhanced 
expression Sca-1, which is downstream of interferon--receptor (IFNAR)-STAT1 signaling. 
Enhanced type I IFN signaling in IRF-2-/- mice induces Sca-1. Sca-1 cell-surface 
glycoprotein is used routinely as a marker of adult HSCs, allowing a >100-fold enrichment 
of these rare cells from the bone marrow of adult mice. The Sca-1 protein is encoded by the 
Ly-6A/E gene. This protein is highly inducible by IFNs - and -, tumor necrosis factor 
(TNF) and interleukin-1 (IL-1) (Khan et al., 1990, 1993). The presence of a consensus 
sequence for IFN--responsive elements has been reported to be localized to the Ly-6A/E 
genes promoter (Ma et al., 2001). Ito et al investigated that competitive repopulation assay 
using HSC from Sca-1-deficient mice and colony formation assay for Sca-1-deficient bone 
marrow. They demonstrated that Sca-1 is required for regulating HSC self-renewal and 
development of committed progenitor cells, megakaryocytes, and platelets  (Ito et al. 2003). 
Bradfute et al investigated the effect of Sca-1 on HSC function and demonstrated that Sca-1 
affects c-kit expression, the lineage fate of peripheral blood cells after transplantation, and 
may be dispensable for HSC self-renewal (Bradfute et al., 2005).We also observed higher 
populations of KSL cells in the spleens of IRF-2-/- mice (data not shown).  
HSCs are contained within the CD150+CD48- population of KSL cells. There were far fewer 
CD150+CD48- cells in the KSL fraction in IRF-2-/- mice than in wild-type mice (0.97% 
versus 0.001%). In contrast, within the CD150+ CD48-Lin- subset, the fraction of KSL cells in 
wild-type mice and IRF-2-/- mice was 31.58% and 0.001%, respectively. Thus, the 
population of CD150+CD48-KSL cells was very low in IRF-2-/- mice (Fig. 2B). IRF-2 is 
known to be a transcription factor that attenuates type I IFN (IFN-/IFN-) signaling as 
indicated by the up-regulation of IFN-inducible genes in IRF-2-/-mice. IFN-/IFN- 
produced by plasmacytoid dendritic cells (DCs) in IRF-2-/- mice may have stimulated HSC 
proliferation, which resulted in loss of stem cells (Fig. 2C). 
The number of KSL side-population (SP) cells was much lower in bone marrow cells from 
IRF-2-/- mice compared to those from wild-type mice (Fig. 3). We observed an increased cell 
number in the KSL fraction and a great reduction in the number of HSCs in the KSL fraction 
among the bone marrow cells of IRF-2-/- mice.  
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Fig. 2. (A) Lin-c-kit+sca-1+ cells were isolated from wild-type (WT) and IRF-2-/- bone 
marrow cells (KO), and then Lin-CD48-CD150+ cells were isolated from the KSL fraction. 
(B) Lin-c-kit+sca-1+ cells were isolated from Lin-CD48-CD150+ cells derived from the bone 
marrow cells of IRF-2-/- mice. (C) Chronic IFN stress model in KSL cells of IRF-2-/- mice. 
ISGs : Interferon-stimulated genes 
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Fig. 3. Reduction in side population of KSL cells in the bone marrow cells from wild-type 
(WT) and IRF-2-/- mice (IRF-2KO). VP (verapamil) treatment eliminated the side 
population. 
2.1.1 In vitro differentiation of KSL 
To analyze the population of the KSL fraction in bone marrow from IRF-2-/- mice, an in 
vitro colony-forming assay was performed. The assay showed enhanced 
granulocyte/macrophage progenitor activity and reduced numbers of megakaryocyte 
progenitors in KSL derived from bone marrow of IRF-2-/- mice (Fig. 4). We did not see any 
difference for erythrocyte progenitors in the bone marrow derived-KSL cells in either wild-
type or IRF-2-/-mice.  
To compare ex vivo expansion of HSC between wild type and IRF-2-/-mice, KSL cells were 
plated at a density of 1 cell/well in Terasaki plates in 20 μL serum-free medium. The 
Terasaki single colony assay showed the significant colony formation activity in KSL cells 
from IRF-2-/- mice although its activity is less than that of wild-type mice (Fig. 5). In vitro 
culture assay, KSL cells from IRF-2-/- mice make colonies in the presence of cytokines, 
despite of near complete reduction of HSC population (Fig.2). 
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Fig. 4. Clonogenic progenitor assay. Two hundred KSL cells were subjected to a colony-
forming unit-granulocyte/macrophage CFU-GM assay in methylcellulose medium M3231 
(Stem Cell Technologies, Vancouver, BC, Canada) consisting of 1% methylcellulose, 30% 
fetal calf serum (FCS), 1% bovine serum albumin (BSA), 10 ng/mL stem cell factor (SCF), 
25 ng/mL Flt ligand, 25 ng/mL thrombopoietin (TPO), 5 ng/mL IL-3 and 25 ng/mL 
granulocyte colony-stimulating factor (G-CSF). For the burst-forming units-erythroid 
(BFU-E) assay, 200 KSL cells were cultured in M3231 consisting of 1% methylcellulose, 
30% FCS, 1% BSA, 50 ng/mL SCF, 50 ng/mL TPO and 5U/mL erythropoietin (EPO) for 7 
days. To perform the mouse CFU-megakaryocytic (Mk) assays, 4x103  KSL cells were 
mixed with Megacult-C 04900 together with 1.1 mg/mL collagen, 50 ng/mL TPO and 10 
ng/mL IL-3 in 0.75 mL and added to the wells of chamber slides (177429, LAB-TEK Brand 
Products). Cells were cultured at 37C in an incubator with an atmosphere of 5% CO2 and 
>95% humidity for 7 days. The chamber slides were placed in acetone solution to fix the 
cells and dried, and the dried slides were then stained with acetylthiocholiniodide 
solution (Sigma, St Louis, MO). After they were stained with hematoxylin, megakaryocyte 
colonies were counted. *P<0.05 (Student t test). Data are representative of two 
independent experiments (mean ±SD). 
 
Fig. 5. Terasaki single colony assay. The KSL fraction from wild-type and IRF-2-/- bone 
marrow cells was fractionated to single cells in Terasaki plates by cell sorter (JSAN). Single 
cells were cultured with cytokines (hTPO, mSCF, mIL-3 and mFlt-3 ligand) containing 10% 
BSA and 2-mercaptethanol (0.01 M) in X-VIVO medium for 10 days. Colonies in each well 
were analyzed. <50 indicates wells that contain under 50 colonies in one well. >50 indicates 
wells that contain over 50 colonies. 0 indicates the wells containing no colony. 
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HSCs in wild-type mice were predominantly in a quiescent, intracellular Ki67-negative 
(icKi67 Hoechst low) G0 phase. Quiescent cells were observed more frequently in KSL cells 
derived from IRF-2-/- mice, although the population of HSCs was much smaller than that of 
wild-type mice (Fig. 6).  
2.1.2 Gene expression of KSL cells 
Next, we investigated the KSL-specific gene expression in KSL cells derived from bone 
marrow cells of IRF-2-/-mice. Expression levels of GATA-2 and Tie2 in IRF-2-/- mice were 
similar to those of wild-type, but p57 expression was much lower than that of wild-type 
(Fig. 7A). Reduced p57 gene expression is associated with decreased numbers of HSCs in the 
KSL population, and the increased number of cells in G0 phase may be associated with an 
increased frequency of quiescent KSL cells in bone marrow cells from IRF-2-/- mice (Fig. 6). 
When types I and II IFN were analyzed, expression of IFN-, but not of IFN- and - was 
decreased in the KSL fraction of IRF-2-/- mice under no stimulation (Fig. 7BC). Expression 
of Sca-1 was enhanced in the KSL fraction and in whole bone marrow in the IRF-2-/- mice. 
We examined PKR, TNF-a, adenosine deaminase 1 (ADAR1) expression which is known to 
be a suppressor of interferon signaling (Hartner et al. 2009 ) and Bmi1, which is down 
regulated in IRF-2 deficient HSC (Sato et al 2009). Expressions of ADAR1, PKR, Bmi1 and 
TNF- were comparable between wild-type and IRF-2-deficient mice (Fig. 7C). 
 
 
 
 
 
 
 
 
 
Fig. 6. Cell cycle analysis. Populations of KSL cells were isolated from bone marrow cells of 
IRF-2-/-mice and stained with Ki67 and Hoechst. Numbers indicate the percentage of cells 
in G0 phase. Data are representative of two independent experiments.  
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Fig. 7.  Gene expression in KSL (A and B) and bone marrow cells (C) from wild-type and 
IRF-2-/- mice. Data represent the mean ± SD of triplicate reactions and are representative of 
two independent experiments.  
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2.1.3 Transplantation 
To examine the functional properties of IRF-2-/- KSL cells, transplantation analysis was 
performed. In competitive repopulation assays, a constant number (1x105) of wild-type 
competitor cells was mixed with 1,500 KSL cells from IRF-2-/- mice and injected into 
lethally irradiated Ly5.1 mice. Engraftment analysis by peripheral blood chimerism (CD45.2 
versus CD45.1 x CD45.2) at 4, 8 and 12 weeks after transplantation showed a profound 
deficit in wild-type recipient marrow, as peripheral blood elements derived from IRF-2-/- 
HSCs were progressively lost in favor of wild-type cells (Fig. 8A). Many more KSL cells 
could be engrafted into recipient mice if HSCs existed in the KSL fraction. However, a 24-
fold larger number of cells also failed to rescue the recipients (Fig. 8B). When cells from the 
lineage-CD48 fraction were injected into recipients, no engraftment was shown in the 
recipients injected with cells from IRF-2-/- mice (Fig. 8C). The proportions of cells in the 
lineage-CD48 fraction isolated from both wild-type and IRF-2-/- mice were very similar 
(3.4% versus 2.9%). However, the number of CD150-positive cells was much lower in the 
IRF-2-/- mice compared to the wild-type mice (Fig.1).  
To examine whether HSCs existed in fractions other than the KSL fraction of bone marrow 
cells in IRF-2-/- mice, whole bone marrow cells were injected into recipient mice and 
noncompetitive transplant assays were also performed. Transplantation of 1x105 wild-
type bone marrow cells is normally sufficient to rescue and fully repopulate the 
hematopoietic systems of all lethally irradiated recipients. This dose of cells from KO 
donors failed to rescue any recipients from lethal irradiation, indicating impaired self-
renewal of HSCs in whole bone marrow cells derived from IRF-2-/- cells. A dose of 2 x 106 
cells from IRF-2-/- mice could rescue recipients from lethal irradiation, although the 
engraftment efficiency was poorer than that of wild-type at 1 month after transplantation 
(Fig. 8D).  
 
 
 
 
 
 
 
A 
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Fig. 8.  Transplantation analysis. Cells in the KSL population were isolated from IRF-2-/- 
mice (Ly5.2) and injected into X-irradiated mice. Peripheral blood cells were analyzed 4, 8 
and 12 weeks after transplantation. (A) Percentage of donor-derived KSL cells (1500-cell 
injection) in the blood. (B) Percentage of KSL derived from IRF-2-/- mice (injection of 
indicated cell numbers) in the blood. (C) Percentage of Lin-CD48- cells from bone marrow of 
wild-type and IRF-2-/- mice in the blood. (D) Percentage of donor-derived whole bone 
marrow cells in the blood. Cells were grown in one of three mice injected with 2x106 whole 
bone marrow cells derived from IRF-2-/- mice. Representative data are shown from three 
independent experiments. 
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An IRF-2-expressing retrovirus (Masumi et al. 2009) was transduced into the KSL fraction of 
IRF-2-deficient mouse bone marrow cells. When these IRF-2-expressing KSL cells were 
injected into lethally irradiated recipients, no sufficient rescue of engraftment was observed 
(data not shown). KSL cells from IRF-2-deficient mice may be distinct from those of wild-
type mice. IRF-2 expression does not contribute to rescue the HSC function in KSL cells from 
IRF-2-/- mice in vivo.  
IRF-2-/- mice were previously reported to be more sensitive to 5-fluorouracil (5-FU) than 
IRF-2+/- mice because of a progressive decrease in functional HSCs in IRF-2-/- mice (Sato et 
al., 2009). We treated both IRF-2-/- and wild-type mice weekly with 5-FU. Four of the IRF-2-
/- mice died after the initial injection, but one mouse lived after three injections. We 
conclude that quiescent HSCs are present in whole bone marrow from IRF-2-/- mice, 
although the IRF-2-/- mice are more sensitive than wild-type (Fig. 9). As seen in Fig. 8D and 
Fig. 9, HSC-like cells, which may be isolated using cell surface markers distinct from KSL 
cells, are thought to be present in IRF-2-/-mice bone marrow cells (Fig. 10). 
 
 
 
 
 
 
 
 
 
 
 
Fig. 9. Rate of survival (%) of wild-type and IRF-2-/- mice that were injected weekly with 
150 mg/kg body weight of 5-FU (Sigma Chemical Co.); n= 5 for each group.  
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Fig. 10.  HSC-like cells will be appeared in IRF-2-/- mice bone marrow cells (Refer to 
Fig.2C). IRF-2 may inhibit the down-regulation of CD150 gene expression by type I IFN. 
2.2 Progenitors in bone marrow cells from IRF-2-/- mice 
Next we analyzed the progenitor population in bone marrow cells from IRF-2-/- mice. 
Akashi et al proposed the model of major hematopoietic maturation pathways from HSCs 
(Akashi et al. 2000). According to his proposal, granulocyte/macrophage lineage progenitor 
(GMP), megakaryocyte/erythrocyte lineage progenitor (MEP), and common myeloid 
progenitor (CMP) and common lymphoid progenitor (CLP) were isolated from wild-type 
and IRF-2-deficient mice bone marrow. The frequencies of MEPs (Lin-ckitlosca-1-
FcRgloCD34-) and CMPs (Lin-ckitlosca-1-FcRgloCD34+) were slightly decreased in IRF-2-
deficient mice compared to wild-type mice. By contrast, GMPs (Lin-ckitlosca-1-
FcRghighCD34+)  were slightly increased in IRF-2-deficient mice (Fig. 11A). The frequency of 
the CLP compartment in IRF-2-/- mouse bone marrow cells was lower than that from wild-
type bone marrow (Fig. 11B).  
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Fig. 11. (A) Lineage relationships among the myeloid progenitor subsets. MEPs (Lin-
ckitlosca-1-FcRgloCD34-), CMPs (Lin-ckitlosca-1-FcRgloCD34+), and GMPs (Lin-ckitlosca-1-
FcRghighCD34+) are indicated. (B) Common lymphoid progenitors in bone marrow from 
IRF-2-/- mice.  
2.2.1 Mouse colony-forming cell (CFC) assays with bone marrow derived from IRF-2-/- 
mice 
The size of the GMP population from IRF-2-/- mice was higher than that from wild-type. 
We analyzed bone marrow and spleen cells from IRF-2-/- mice with CFU-GM assay. Colony 
numbers were higher in the bone marrow and spleen cells from IRF-2-/- mice, likely to the 
KSL population (Fig. 12 and Fig. 4). 
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Fig. 12. Clonogenic progenitor assay with bone marrow and spleen cells from wild-type and 
IRF-2-/- mice. Assays performed as described in methods for Fig. 4. BM: bone marrow; SP: 
spleen  
2.3 IRF-2 is required for bone marrow lymphopoiesis 
To confirm the direct effect of IRF-2 deficiency in KSL cells, complementary DNA 
microarray analysis was performed on sorted Lin-c-Kit+Sca-1+ cells from bone marrow of 
wild-type and IRF-2-/- mice. This analysis showed that the up-regulated genes included 
IFN-inducible genes, such as Ly6s and Ifits, and the pre-B lymphocyte gene family (data not 
shown). As shown in Fig.13, when bone marrow B cell progenitors are analyzed, severe 
reduction in the frequency of mature IgM+ B cells was detected in the IRF-2-/- mice; and an 
enhanced frequency of pre-pro-B cells was detected in young IRF-2-deficient mice. These 
defects were correlated with the KSL array data (not shown). These data indicate a 
requirement for IRF-2 in maintaining bone marrow B homeostasis and B cell differentiation. 
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A: pre pro-B, B: pro-B, C: pre-B, D: Mature B 
Fig. 13. Loss of IRF-2 in hematopoietic cells results in impaired B cell homeostasis. Top 
panel: FACS analysis of frequencies of B-cell subsets in bone marrow of IRF-2-/- and age-
matched littermate control mice, for expression of B220, IgM, CD43 and CD24. Bottom 
panel: Four to five (each) young (7W) and old (14W) mice were analyzed. The frequency of 
mature B220+IgM+B cells (D) was significantly reduced in both young and old IRF-2-/- 
mice. Young, but not old, IRF-2-/- mice exhibited significant reductions in pre-B fractions 
(C) and increases in pre pro-B fractions (A). 
Fluorescence-activated cell sorting (FACS) analysis of peripheral blood indicated that any 
significant differences in lineage between wild-type and IRF-2-/- mice were not observed 
(data not shown). However, an increase in Gr1+Mac1+ neutrophils and a decrease in B220+ 
cells were detected in the bone marrow and spleens IRF-2-/- mice (Fig.14). These lineage 
populations almost reflect to that of progenitors in IRF-2-/-mice (Fig.11).  
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Fig. 14. Lineage populations in IRF-2-/- mouse bone marrow and spleens. Mononuclear 
cells from mouse bone marrow (BM) or spleen cells were stained with each antibody 
conjugated to PE and analyzed by FACS. Percentage indicates relative counts per whole 
mononuclear cells in each surface marker analysis. 
2.4 Effect of type I IFN in IRF-2-/- mice 
To assess the role of IRF-2 in the regulation of type I IFN signaling, we analyzed gene 
expression in IRF-2-/- mice compared to IRF-2-/- IFNAR-/- dKO mice, which do not 
respond to type I IFN. Sca-1 gene expression was enhanced in the bone marrow of IRF-2-/- 
mice, but not in IRF-2-/-/IFNAR-/- dKO mice. However, reduced expression of IFN- in 
IRF-2-/- mice was not rescued in IRF-2-/-IFNAR-/- dKO mice. Sca-1 expression is regulated 
by IRF-2 and the type I IFN response. However, IFN- may be regulated by IRF-2, 
independent of the type I IFN response. Arakura et al. reported the up-regulation of IFN- 
resulting from aberrant IFN-/IFN- responses in abdominal skin from IRF-2-/- mice 
(Arakura et al., 2007). In the bone marrow and KSL cells of our IRF-2-/- mice, IFN- 
expression was extremely low and the defect in IFN-/IFN- signaling did not rescue the 
expression. IFN-/IFN- expression was not enhanced in bone marrow and KSL cells in 
IRF-2-/- mice in the absence of stimulation (Fig. 8).  
IFN- expression decreased in the bone marrow of both IRF-2-/- mice and IRF-2-/- IFNAR-
/-dKO mice (Fig. 8B and Fig. 15). IFN- reduction is independent of type I IFN signaling in 
bone marrow cells from IRF-2-/- mice. IRF-2 may regulate IFN- gene expression through 
its promoter or other factors. 
  
Fig. 15. Real-time PCR analysis for Sca-1, IFN- and GATA-3 gene expression in bone 
marrow cells from wild-type (WT), IRF-2-/- (KO)and IRF-2-/- IFNAR-/- dKO (DKO)mice. 
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A FACS analysis revealed the reduction of the CD150 surface marker in IRF-2-/- mice. 
Using real-time RT-PCR for expression of the CD150 gene in IRF-2-deficent mouse bone 
marrow, we demonstrated a profound decrease of CD150 gene expression (Fig. 16). 
However, the CD150 expression level in IRF-2-/- IFNAR-/- dKO bone marrow was 
comparable to wild-type mice. These results indicate that CD150 expression is regulated by 
the type I IFN response and is transcriptionally regulated in IRF-2-/-mice (Fig. 16). Sato et 
al. reported that the HSC population, including CD150-positive cells, was reduced through 
the induction of HSC proliferation by type I IFN signaling. However, we revealed another 
mechanism in which IRF-2 or type I IFN signaling directly mediated CD150 gene 
expression. In contrast, more depressed expression of Sca-1 was detected in IRF-2-/- 
IFNAR-dKO mice compared to that in wild type, supporting that Sca-1 expression was 
regulated by the type I IFN system (Fig. 16). 
 
Fig. 16. Real-time PCR analysis for CD150 in bone marrow cells from wild-type (WT), IRF-2-
/- (KO) and IRF-2-/- IFNAR-/- dKO (DKO) mice. 
2.5 IRF-2 interaction with transcription factors in KSL 
We investigated IRF-2-interacting transcription factors that are associated with 
hematopoiesis. TF(Transcriptional factor)-TF analysis indicates that IRF-2 associates 
GATA-1/2. However, we did not observe any difference of GATA-1 (data not shown) 
and GATA-2 (Fig.7A) expressions between wild-type and IRF-2-/- mice mice by KSL 
array data and real-time PCR analysis. We performed in vitro protein interaction 
analysis using 293T culture cells. IRF-2 interacted with GATA-2, but not GATA-1, when 
Flag-tagged IRF-2 and HA-tagged GATAs were transfected into 293T cells. To examine 
which region of IRF-2 interacts with GATA-2, IRF-2 DNA binding domain (DBD) and 
IRF-2 without DBD were incubated with several deletion constructs of GATA-2. The IRF-
2 DNA-binding domain associated with GATA-2, specifically the N-terminal 
transcription activation domain in 293T cells (Fig. 17). 
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Fig. 17. IRF-2 interacts with GATA-2, but not GATA-1. (A) Flag-tagged IRF-2, Flag-tagged- 
IRF-2 DNA binding domain (IRF-2DBD) or Flag-tagged IRF-2 without DBD (IRF-2DBD) 
and HA-tagged GATA-1 or HA-tagged GATA-2 were transfected to 293T cells. Cell lysate 
were incubated with M2-agarose,  and agarose  were washed and eluted with Flag peptide 
solution.  Eluted fraction were electrophoresed and Western blot analysis was performed. 
(B) Protein structure of mouse GATA-2 and its mutants (GATA-24, GATA-25, GATA-22 
and GATA-26) were shown (left) and numbers indicate exons of GATA-2.  Each exon 
deletion mutants tagged with HA was incubated with Flag-tagged IRF-2.  Exon2 
(transcriptional activation domain) in GATA-2 has high affinity for binding with IRF-2 
(right). – indicates non-specific bands. 
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We found that GATA-3 gene expression was decreased in IRF-2-deficient bone marrow and 
KSL cells by KSL array data and real-time PCR analysis (Fig. 15). GATA-3 gene expression 
was comparable to that in IRF-2-/- IFNAR-/- dKO mice, suggesting that the type I IFN 
response affects GATA-3 expression in IRF-2-/- mice. To examine GATA-3 interacts with 
IRF-2, Flag-tagged IRF-2 and myc-GATA-3 expression vectors were transfected to 293T cells. 
We show that GATA-3 interacted with IRF-2 in 293T cells (Fig. 18). 
 
Fig. 18. IRF-2 interacts with GATA-3. Flag-tagged IRF-2 and Myc-tagged GATA-3 were 
transfected to 293T cells. Western blot analysis was performed as described in Fig.17.  
In our investigation, GATA-2 and GATA-3 associated with IRF-2 in the in vitro cell culture 
system. GATA-2 is expressed abundantly in the mouse HSC population and is necessary for 
hematopoietic differentiation (Kitajima et al. 2006). GATA-1 is expressed in 
megakaryocyte/erythrocyte precursors (MEP) and their progenitors, and GATA-3 is 
expressed in common lymphoid precursors (CLPs) and T cells. There are very few reports 
regarding GATA-3 expression in HSCs, although we found that the GATA-3 expression 
level changed in IRF-2-deficient bone marrow and KSL in microarray and real time PCR 
analysis. Previous reports have shown that forced GATA-3 expression into mouse HSCs 
induces differentiation toward erythrocytes and megakaryocytes (Chen and Zhang 2001). 
As indicated by our investigation, GATA-3 may be important for the maintenance of HSC 
cooperation with IRF-2 or IFN signaling. These findings indicate that the interactions 
between IRF-2 and the GATAs are required to maintain HSC function in mouse bone 
marrow cells. Interactions between GATA-2 and GATA-3 with IRF-2 in HSCs should be 
clarified in future experiments.  
3. Conclusion 
IRF-2 exists high in the mouse bone marrow HSC population and helps maintain the 
protective immune response, which responds to viral or bacterial infection and 
inflammation, resulting in IFN producing system. HSCs are essential for the production of 
immune cells, such as myeloid or lymphoid cells. Recently, interferon treatment has been 
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reported to be a target for cancer stem cells. Under chronic interferon stimulation, such as in 
an IRF-2-deficient condition, not only HSCs, but also cancer stem cells can be activated. 
Blocking the IRF-2 function may induce to eliminate of cancer stem cell  through IFN 
signaling.  However, the possibility of the presence of HSC-like cells in IRF-2 deficient mice 
cell population necessitates further investigation because IRF-2 in part regulates HSC 
populations independent of the type I IFN system in an another possible mechanism. 
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